EUVIMEDEUVIMED entdecken
Fallbericht

Gliptin-induced bullous pemphigoid

Maria Ganeva, Tanya Gancheva, Karen Manuelyan, Evgenya Hristakieva

Int. Journal of Clinical Pharmacology and Therapeutics · 2024

DOI: 10.5414/cp204478 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Maria Ganeva und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Pemphigoid, Bullous, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl-Peptidase IV InhibitorsPemphigoid, BullousDiabetes Mellitus, Type 2HumansAgedLinagliptinHypoglycemic AgentsAdrenal Cortex Hormones

Substanzen

Dipeptidyl-Peptidase IV InhibitorsLinagliptinHypoglycemic AgentsAdrenal Cortex Hormones

Zitieren

APA

Ganeva, M., Gancheva, T., Manuelyan, K., & Hristakieva, E. (2024). Gliptin-induced bullous pemphigoid. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204478

Vancouver

Ganeva M, Gancheva T, Manuelyan K, Hristakieva E. Gliptin-induced bullous pemphigoid. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204478

BibTeX
@article{Ganeva2024,
  author = {Ganeva, Maria and Gancheva, Tanya and Manuelyan, Karen and Hristakieva, Evgenya},
  title = {Gliptin-induced bullous pemphigoid},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.5414/cp204478}
}
Kostenlos starten →